 Interferon Type I
"Interferon Type I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA).
| Descriptor ID |
D007370
|
| MeSH Number(s) |
D12.644.276.374.440.890 D12.776.467.374.440.890 D23.529.374.440.890
|
| Concept/Terms |
Interferon Type I- Interferon Type I
- Type I Interferons
- Interferons, Type I
- Interferons Type I
- Type I Interferon
- Interferon, Type I
|
Below are MeSH descriptors whose meaning is more general than "Interferon Type I".
Below are MeSH descriptors whose meaning is more specific than "Interferon Type I".
This graph shows the total number of publications written about "Interferon Type I" by people in this website by year, and whether "Interferon Type I" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 2 | 0 | 2 | | 1999 | 1 | 0 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2004 | 0 | 1 | 1 | | 2005 | 1 | 0 | 1 | | 2006 | 2 | 0 | 2 | | 2007 | 2 | 0 | 2 | | 2008 | 1 | 0 | 1 | | 2009 | 0 | 1 | 1 | | 2010 | 2 | 1 | 3 | | 2011 | 5 | 1 | 6 | | 2012 | 1 | 1 | 2 | | 2013 | 3 | 0 | 3 | | 2014 | 4 | 2 | 6 | | 2015 | 0 | 1 | 1 | | 2016 | 3 | 0 | 3 | | 2017 | 2 | 2 | 4 | | 2018 | 3 | 5 | 8 | | 2019 | 2 | 2 | 4 | | 2020 | 2 | 3 | 5 | | 2021 | 6 | 1 | 7 | | 2022 | 4 | 1 | 5 | | 2023 | 4 | 0 | 4 | | 2024 | 1 | 2 | 3 | | 2025 | 0 | 1 | 1 | | 2026 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Interferon Type I" by people in Profiles.
-
Zeng Y, Xu J, Wang J, Xue L, Liu J, Geisler HC, Ma X, Melamed JR, Shi Q, Padilla MS, Luo Z, Zhu J, Thatte AS, Figueroa-Espada CG, Ang MJY, Murray AM, Yamagata HM, Kim D, Metzloff AE, Weissman D, Mitchell MJ. mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity. Proc Natl Acad Sci U S A. 2026 Jul 14; 123(28):e2525718123.
-
Shaw SC, Jamil TL, Heslop G, Fleck JT, Johnson W, Lorenz BP, Drigot Z, Harris JK, Gitomer SA, Clark SE. Type I interferon signaling in hematopoietic cells impairs neutrophil antibacterial function in the middle ear during viral co-infection. Cell Rep Med. 2026 Jun 16; 7(6):102846.
-
Owen MC, Li DY, Shin H, Gu W, Parvathaneni A, Kadyrov FF, Wang X, Sticco-Ivins M, Bonnici G, Nelson SL, Dun H, Hyacinth S, Giangrasso SC, Chou C, Lin CY, Cain MT, Pedroza A, Dalal A, Sallam K, Boyd J, Woo J, Amrute JM, Cheng P, Lavine KJ, Kopecky BJ. Single-cell and spatial transcriptomics identify immune-stromal interactions in cardiac allograft vasculopathy. Nat Cardiovasc Res. 2026 May; 5(5):439-455.
-
Stark DS, King M, Ibler AEM, Srour S, Brown F, Sheffield J, Baseer N, Vernon EG, Zhang Y, Staples C, Radoshevich L, Humphreys D. Typhoid Toxin of Salmonella enterica Induces ISG15 Responses Mediating Host Cell Survival and Counteracting Intracellular Infection. Mol Microbiol. 2026 06; 125(6):475-492.
-
Shmizu M, Kaneko S, Shimbo A, Hatano M, Miyaoka F, Irabu H, Akutsu Y, Hayashi Y, Akamine K, Mori M. Anifrolumab for refractory cutaneous lupus lesions in pediatric systemic lupus erythematosus. Lupus. 2025 Apr; 34(5):533-536.
-
Bullock CB, Wang L, Ware BC, Wagoner N, Ohara RA, Liu T-T, Desai P, Peters B, Murphy KM, Handley SA, Morrison TE, Diamond MS. Type I interferon signaling in dendritic cells limits direct antigen presentation and CD8+ T cell responses against an arthritogenic alphavirus. mBio. 2024 12 11; 15(12):e0293024.
-
Ueda MT, Inamo J, Miya F, Shimada M, Yamaguchi K, Kochi Y. Functional and dynamic profiling of transcript isoforms reveals essential roles of alternative splicing in interferon response. Cell Genom. 2024 10 09; 4(10):100654.
-
Guak H, Weiland M, Ark AV, Zhai L, Lau K, Corrado M, Davidson P, Asiedu E, Mabvakure B, Compton S, DeCamp L, Scullion CA, Jones RG, Nowinski SM, Krawczyk CM. Transcriptional programming mediated by the histone demethylase KDM5C regulates dendritic cell population heterogeneity and function. Cell Rep. 2024 08 27; 43(8):114506.
-
Varnet M, Kayani S, Wang C. Diagnostic Journey and Therapeutic Intervention of a Type-1 Interferonopathy in a Newborn (P6-8.002). Neurology. 2024 Apr 09; 102(7_supplement_1):6859.
-
Hashimi M, Sebrell TA, Hedges JF, Snyder D, Lyon KN, Byrum SD, Mackintosh SG, Crowley D, Cherne MD, Skwarchuk D, Robison A, Sidar B, Kunze A, Loveday EK, Taylor MP, Chang CB, Wilking JN, Walk ST, Schountz T, Jutila MA, Bimczok D. Antiviral responses in a Jamaican fruit bat intestinal organoid model of SARS-CoV-2 infection. Nat Commun. 2023 10 28; 14(1):6882.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|